Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access

Editor-in-Chief:

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Pancreatic Cancer Therapy (Guest Editor: Dr. Felix Ruckert)] promotion: free to download

Volume:11   Issue:5
Pp: 408-410
Susanne Sebens and Holger Kalthoff
DOI: 10.2174/187152011795677418

An Update on Molecular Research of Pancreatic Adenocarcinoma

Volume:11   Issue:5
Pp: 411-417
Christian Krautz, Felix Ruckert, Hans-Detlev Saeger, Christian Pilarsky and Robert Grutzmann
DOI: 10.2174/187152011795677409

Combination Therapy for the Treatment of Pancreatic Cancer

Volume:11   Issue:5
Pp: 418-426
William Greenhalf and Amy Thomas
DOI: 10.2174/187152011795677391

Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer

Volume:11   Issue:5
Pp: 427-433
Simon Rieder, Christoph W. Michalski, Helmut Friess and > Kleeff
DOI: 10.2174/187152011795677454

Aptamers: Potential Applications to Pancreatic Cancer Therapy

Volume:11   Issue:5
Pp: 434-441
Kristy L. Rialon and Rebekah R. White
DOI: 10.2174/187152011795677472

Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials

Volume:11   Issue:5
Pp: 455-463
Marco Falasca, Federico Selvaggi, Richard Buus, Sara Sulpizio and Charlotte E. Edling
DOI: 10.2174/187152011795677382

Anti-Angiogenic Agents in Pancreatic Cancer: A Review

Volume:11   Issue:5
Pp: 464-469
Murwarid M. Assifi and Oscar J. Hines
DOI: 10.2174/187152011795677463

Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms

Volume:11   Issue:5
Pp: 470-478
Nicholas J. Zyromski and Patrick B. White
DOI: 10.2174/187152011795677445